1 , 2 , 4 A meta-analysis of 3 RCTs comparing DOACs with VKAs after PCI, PIONEER AF-PCI (Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects with Atrial Fibrillation who Undergo Percutaneous Coronary Intervention) (rivaroxaban), RE-DUAL PCI trial (Randomized Evaluation of Dual Antithrombotic Therapy with Dabigatran versus Triple Therapy with Warfarin in Patients with Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) (dabigatran), and AUGUSTUS (Open-Label, 22 Factorial, Randomized, Controlled Clinical Trial to Evaluate the Safety of Apixaban vs Vitamin K Antagonist and Aspirin vs Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention) (apixaban), showed a 42% relative risk reduction for major bleeding in DOAC-based regimens compared with VKA-based regimens (OR, 0.577 [95% CI, 0.477-0.698]

It depends on smarter governance , one that distinguishes regulation from enforcement, integrates emerging scientific evidence without selective bias, and remains transparent about uncertainty and tradeoffs
Speaking of menthol flavors, you gotta check out this flair disposable in menthol flavor
A plate was set down on the narrow table outside the door - enough for one
He had never tried quitting nicotine entirely, but he knew he didnt want to carry a vape around at his own wedding this past March
While MERV ratings go all the way up to 20, high-rated filters are generally reserved for health and research facilities